Development and Validation of a Sexual Quality of Life Score for Youths With Inflammatory Bowel Disease
Clinical Scorecard: Creation and Assessment of a Sexual Quality of Life Index for Young Individuals with Inflammatory Bowel Disease
At a Glance
| Category | Detail |
|---|
| Condition | Inflammatory Bowel Disease (IBD) |
| Key Mechanisms | IBD impacts sexual quality of life through symptoms such as fatigue, abdominal pain, body image concerns, and fear of anal leakages |
| Target Population | Youth aged 15-25 years with IBD |
| Care Setting | Multicenter clinical settings including pediatric and gastroenterology consultations |
Key Highlights
- BLOOMI is a newly developed and validated sexual quality of life score specifically designed for young patients with IBD aged 15-25 years.
- The score integrates items from validated tools (IIEF and SFQ28) and includes IBD-specific sexual health concerns.
- BLOOMI facilitates discussion of sexual health in clinical consultations by providing an easy-to-use, visually interpretable format.
Guideline-Based Recommendations
Diagnosis
- Use validated sexual quality of life scores such as BLOOMI to screen for sexual challenges in young IBD patients.
- Complement sexual QoL assessment with depression and anxiety screening tools.
Management
- Address sexual health proactively during consultations, overcoming barriers related to clinician discomfort and patient embarrassment.
- Use BLOOMI score results to guide discussions and interventions tailored to sexual dysfunction and QoL impairments.
Monitoring & Follow-up
- Regularly assess sexual quality of life in adolescents and young adults with IBD using BLOOMI to monitor changes over time.
- Evaluate associated symptoms such as fatigue, abdominal pain, and body image concerns that correlate with sexual QoL.
Risks
- Recognize that untreated sexual dysfunction and poor sexual QoL may negatively impact romantic relationships and overall well-being in youth with IBD.
Patient & Prescribing Data
Young individuals aged 15-25 years diagnosed with IBD
BLOOMI score identifies sexual dysfunction prevalence (e.g., 19.1% erectile dysfunction in males) and domains affected, guiding personalized care.
Clinical Best Practices
- Incorporate BLOOMI into routine clinical assessments to facilitate open dialogue about sexual health with young IBD patients.
- Ensure multidisciplinary involvement including gastroenterologists, pediatricians, and sexologists for comprehensive care.
- Use non-offensive, age-appropriate language and formats to improve patient comfort and response accuracy.
- Consider the impact of IBD symptoms such as fatigue and body image on sexual quality of life when planning management.
References
